Literature DB >> 26755167

Cure prevents more than transmission of hepatitis C virus.

Harel Dahari1, Scot J Cotler1, Jordan J Feld2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26755167      PMCID： PMC4942376          DOI： 10.1002/hep.28449

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  3 in total

1.  Treatment as prevention: the breaking of taboos is required in the fight against hepatitis C among people who inject drugs.

Authors:  Philip Bruggmann
Journal:  Hepatology       Date:  2013-09-17       Impact factor: 17.425

2.  Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs.

Authors:  Anthony Cousien; Viet Chi Tran; Sylvie Deuffic-Burban; Marie Jauffret-Roustide; Jean-Stéphane Dhersin; Yazdan Yazdanpanah
Journal:  Hepatology       Date:  2015-12-18       Impact factor: 17.425

3.  Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

Authors:  Adriaan J van der Meer; Bart J Veldt; Jordan J Feld; Heiner Wedemeyer; Jean-François Dufour; Frank Lammert; Andres Duarte-Rojo; E Jenny Heathcote; Michael P Manns; Lorenz Kuske; Stefan Zeuzem; W Peter Hofmann; Robert J de Knegt; Bettina E Hansen; Harry L A Janssen
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272
  3 in total
  2 in total

1.  High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network Members.

Authors:  Basmattee Boodram; Anna L Hotton; Louis Shekhtman; Alexander Gutfraind; Harel Dahari
Journal:  J Urban Health       Date:  2018-02       Impact factor: 3.671

2.  Future complications of chronic hepatitis C in a low-risk area: projections from the hepatitis c study in Northern Norway.

Authors:  H Kileng; L Bernfort; T Gutteberg; O S Moen; M G Kristiansen; E J Paulssen; L K Berg; J Florholmen; R Goll
Journal:  BMC Infect Dis       Date:  2017-09-16       Impact factor: 3.090
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.